|
Elena Maryamchik MD, MBA
Director of Cell Therapy Laboratory and Assistant Attending in Transfusion Medicine
Memorial Sloan Kettering Cancer Center
New York, NY
USA
|
After receiving a dual MD/MBA degree from the University of Miami in 2016, Elena Maryamchik completed Clinical Pathology residency at the Massachusetts General Hospital, Cell and Gene Therapy Fellowship at the University of Pennsylvania/Children’s Hospital of Philadelphia, and Transfusion Medicine Fellowship at Harvard. She is currently a Director of Cell Therapy Laboratory, and an Assistant Attending in Transfusion Medicine at Memorial Sloan Kettering Cancer Center. Her interests include implementing point-of-care manufacturing of cell therapy products, such as CAR-T cells, antigen-specific lymphocytes and anti-cancer vaccines, in the setting of a clinical stem-cell laboratory, improving stem cell enumeration and expanding post-thaw viability monitoring into daily use to optimize HPC dosing and improve patient outcomes, developing in-house training programs to facilitate entry of qualified technicians into the field of cell therapy, designing resident and fellow educational programs to train the next generation of cell therapy leaders, and optimizing operations of a clinical laboratory to meet the rising demands of the cell therapy field. As an early-stage professional, she is a member of ISCT Lab Practices Committee, ISCT Expanded Access Working Group, and an ASTCT representative to the AABB Circular of Information for Cellular Therapies Task Force.